Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 700 results found. Search for [ Data Sciences ]

Results 60 to 80 of 700
BusinessToday.In
New Delhi, June 30, 2020
TikTok removed from Android, Apple play stores after govt ban on 59 Chinese appsA day after the Indian government ordered a ban on 59 Chinese mobile apps over security reasons amid the India-China border tension, the popular video app TikTok has been removed from Android's Play Store and Apple store. The popular Chinese app has over 120 million active users, mostly those in the 20s, in India alone. Mukesh Ambani's RIL set to acquire Kishore Biyani-led Future GroupMukesh Amban...


BusinessToday.In
June 29, 2020
Announcing the same at a virtual media briefing, Delhi Chief Minister Arvind Kejriwal stated that the plasma bank will start operating in the national capital in the next two working days


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


Ushasri T.S & Jitamitra Desai
June 26, 2020
The coronavirus might linger on for many years, but effective e-commerce and hybrid fulfilment methods will help propel the retail industry forward and help retailers weather such storms now and in the future


BusinessToday.In
New Delhi, June 24, 2020
Coronavirus testing facilities in India: Check out cost of tests, COVID-19 testing centres near you as listed by ICMR


Joe C Mathew
June 24, 2020
Patanjali claims that 69 percent of the patients showed recovery on Day 3 PCR tests and 100 percent recovery on test conducted on the 7th day, which was 35 percent better recovery than the patient group on placebo


Reuters
June 23, 2020
Cipla and privately held Indian drugmaker Hetero Labs on Sunday gained approval to sell generic versions of remdesivir in the country. Hetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees


BusinessToday.In
June 23, 2020
Patanjali's ayurvedic medicine for COVID-19: Baba Ramdev claimed that his ayurvedic drugs have shown 100 per cent favourable results during the clinical trial


PB Jayakumar
June 22, 2020
Pharma major is hopeful of exporting Fabiflu after the study proves efficacy of the drug in coronavirus treatment


BusinessToday.In
New Delhi, June 21, 2020
These two companies have been approved at a time when coronavirus cases in India are spiralling like never before and putting tremendous pressure on our healthcare system


Joe C Mathew
June 16, 2020
The report, \"Indian Roots, American Soil 2020\" is a state-by-state breakdown of tangible investments made and jobs created by 155 surveyed Indian companies doing business in all 50 states, as well as Washington, D.C., and Puerto Rico


PB Jayakumar
June 16, 2020
About six Indian companies like Cipla, Jubilant, Hetero, Syngene, Dr Reddy's and Zydus Cadila were licensed to make and distribute the drug in over 120 geographies


BusinessToday.In
June 15, 2020
Stock Market LIVE Updates: IndusInd Bank, followed by Tata Steel, Bajaj Finance, ICICI Bank, Axis Bank, NTPC, SBI, HDFC Bank and SBI were among the top laggards in the Sensex pack. On the other hand, Sun Pharma, Infosys, Nestle India and Asian Paints were among the top gainers


Associated Press
June 13, 2020
Four companies -- Hetero, Jubilant Life Sciences, Cipla and Mylan NV -- with which the original drug maker, Gilead Sciences Inc, have entered into non-exclusive licensing agreements are still awaiting nod from the DCGI for manufacturing and selling of remdesivir in India


BusinessToday.In
New Delhi, June 11, 2020
Coronavirus vaccine update: Johnson and Johnson has said that it has pushed up clinical trials by two months; Japanese biotech company AnGes Inc expects its coronavirus vaccine to be ready by the first half of 2021 if production and supply goes smoothly


Reuters
June 10, 2020
Macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study


BusinessToday.In
New Delhi, June 8, 2020
Coronavirus treatment: DCGI has asked the five companies concerned to furnish various sets of data including animal toxicity, stability study etc


PTI
June 2, 2020
The company's annual report for 2019-20 showed that his compensation included Rs 16.85 crore in salary, Rs 17.04 crore in stock options and Rs 38 lakh


Reuters
June 2, 2020
Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials


PTI
June 2, 2020
The drug has been allowed for restricted emergency use for treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children hospitalised with severe symptoms, subject to several safeguards, the source said


PAGES 4 OF 35  12345